 | • レポートコード：QFJ1-6002 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、サルコペニア治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（プロテインサプリメント、カルシウムサプリメント、その他）、用途別市場規模（オンライン薬局、小売薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・サルコペニア治療の市場動向 ・企業の競争状況、市場シェア ・サルコペニア治療の種類別市場規模と予測2016-2027（プロテインサプリメント、カルシウムサプリメント、その他） ・サルコペニア治療の用途別市場規模と予測2016-2027（オンライン薬局、小売薬局） ・サルコペニア治療の北米市場規模2016-2027（アメリカ、カナダ） ・サルコペニア治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・サルコペニア治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・サルコペニア治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・サルコペニア治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Abbott Laboratories、Nestlé、Pfizer、Amway、By-health、Usana、A&Z Pharmaceutical、GlaxoSmithKline、Bayer、H&H、Blackmores、Zhendong Group） ・結論 |
Sarcopenia is a type of muscle loss (muscle atrophy) that occurs with aging and/or immobility.
Market Analysis and Insights: Global Sarcopenia Therapeutic Market
The global Sarcopenia Therapeutic market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Sarcopenia Therapeutic market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Sarcopenia Therapeutic market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Sarcopenia Therapeutic market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Sarcopenia Therapeutic market.
Global Sarcopenia Therapeutic Scope and Market Size
Sarcopenia Therapeutic market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Sarcopenia Therapeutic market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Protein Supplement
Calcium Supplement
Other
Segment by Application
Online Pharmacies
Retail Pharmacies
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Abbott Laboratories
Nestlé
Pfizer
Amway
By-health
Usana
A&Z Pharmaceutical
GlaxoSmithKline
Bayer
H&H
Blackmores
Zhendong Group
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Sarcopenia Therapeutic Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Protein Supplement
1.2.3 Calcium Supplement
1.2.4 Other
1.3 Market by Application
1.3.1 Global Sarcopenia Therapeutic Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Online Pharmacies
1.3.3 Retail Pharmacies
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Sarcopenia Therapeutic Market Perspective (2016-2027)
2.2 Sarcopenia Therapeutic Growth Trends by Regions
2.2.1 Sarcopenia Therapeutic Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Sarcopenia Therapeutic Historic Market Share by Regions (2016-2021)
2.2.3 Sarcopenia Therapeutic Forecasted Market Size by Regions (2022-2027)
2.3 Sarcopenia Therapeutic Industry Dynamic
2.3.1 Sarcopenia Therapeutic Market Trends
2.3.2 Sarcopenia Therapeutic Market Drivers
2.3.3 Sarcopenia Therapeutic Market Challenges
2.3.4 Sarcopenia Therapeutic Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Sarcopenia Therapeutic Players by Revenue
3.1.1 Global Top Sarcopenia Therapeutic Players by Revenue (2016-2021)
3.1.2 Global Sarcopenia Therapeutic Revenue Market Share by Players (2016-2021)
3.2 Global Sarcopenia Therapeutic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Sarcopenia Therapeutic Revenue
3.4 Global Sarcopenia Therapeutic Market Concentration Ratio
3.4.1 Global Sarcopenia Therapeutic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Sarcopenia Therapeutic Revenue in 2020
3.5 Sarcopenia Therapeutic Key Players Head office and Area Served
3.6 Key Players Sarcopenia Therapeutic Product Solution and Service
3.7 Date of Enter into Sarcopenia Therapeutic Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Sarcopenia Therapeutic Breakdown Data by Type
4.1 Global Sarcopenia Therapeutic Historic Market Size by Type (2016-2021)
4.2 Global Sarcopenia Therapeutic Forecasted Market Size by Type (2022-2027)
5 Sarcopenia Therapeutic Breakdown Data by Application
5.1 Global Sarcopenia Therapeutic Historic Market Size by Application (2016-2021)
5.2 Global Sarcopenia Therapeutic Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Sarcopenia Therapeutic Market Size (2016-2027)
6.2 North America Sarcopenia Therapeutic Market Size by Type
6.2.1 North America Sarcopenia Therapeutic Market Size by Type (2016-2021)
6.2.2 North America Sarcopenia Therapeutic Market Size by Type (2022-2027)
6.2.3 North America Sarcopenia Therapeutic Market Size by Type (2016-2027)
6.3 North America Sarcopenia Therapeutic Market Size by Application
6.3.1 North America Sarcopenia Therapeutic Market Size by Application (2016-2021)
6.3.2 North America Sarcopenia Therapeutic Market Size by Application (2022-2027)
6.3.3 North America Sarcopenia Therapeutic Market Size by Application (2016-2027)
6.4 North America Sarcopenia Therapeutic Market Size by Country
6.4.1 North America Sarcopenia Therapeutic Market Size by Country (2016-2021)
6.4.2 North America Sarcopenia Therapeutic Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Sarcopenia Therapeutic Market Size (2016-2027)
7.2 Europe Sarcopenia Therapeutic Market Size by Type
7.2.1 Europe Sarcopenia Therapeutic Market Size by Type (2016-2021)
7.2.2 Europe Sarcopenia Therapeutic Market Size by Type (2022-2027)
7.2.3 Europe Sarcopenia Therapeutic Market Size by Type (2016-2027)
7.3 Europe Sarcopenia Therapeutic Market Size by Application
7.3.1 Europe Sarcopenia Therapeutic Market Size by Application (2016-2021)
7.3.2 Europe Sarcopenia Therapeutic Market Size by Application (2022-2027)
7.3.3 Europe Sarcopenia Therapeutic Market Size by Application (2016-2027)
7.4 Europe Sarcopenia Therapeutic Market Size by Country
7.4.1 Europe Sarcopenia Therapeutic Market Size by Country (2016-2021)
7.4.2 Europe Sarcopenia Therapeutic Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Sarcopenia Therapeutic Market Size (2016-2027)
8.2 Asia-Pacific Sarcopenia Therapeutic Market Size by Type
8.2.1 Asia-Pacific Sarcopenia Therapeutic Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Sarcopenia Therapeutic Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Sarcopenia Therapeutic Market Size by Type (2016-2027)
8.3 Asia-Pacific Sarcopenia Therapeutic Market Size by Application
8.3.1 Asia-Pacific Sarcopenia Therapeutic Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Sarcopenia Therapeutic Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Sarcopenia Therapeutic Market Size by Application (2016-2027)
8.4 Asia-Pacific Sarcopenia Therapeutic Market Size by Region
8.4.1 Asia-Pacific Sarcopenia Therapeutic Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Sarcopenia Therapeutic Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Sarcopenia Therapeutic Market Size (2016-2027)
9.2 Latin America Sarcopenia Therapeutic Market Size by Type
9.2.1 Latin America Sarcopenia Therapeutic Market Size by Type (2016-2021)
9.2.2 Latin America Sarcopenia Therapeutic Market Size by Type (2022-2027)
9.2.3 Latin America Sarcopenia Therapeutic Market Size by Type (2016-2027)
9.3 Latin America Sarcopenia Therapeutic Market Size by Application
9.3.1 Latin America Sarcopenia Therapeutic Market Size by Application (2016-2021)
9.3.2 Latin America Sarcopenia Therapeutic Market Size by Application (2022-2027)
9.3.3 Latin America Sarcopenia Therapeutic Market Size by Application (2016-2027)
9.4 Latin America Sarcopenia Therapeutic Market Size by Country
9.4.1 Latin America Sarcopenia Therapeutic Market Size by Country (2016-2021)
9.4.2 Latin America Sarcopenia Therapeutic Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Sarcopenia Therapeutic Market Size (2016-2027)
10.2 Middle East & Africa Sarcopenia Therapeutic Market Size by Type
10.2.1 Middle East & Africa Sarcopenia Therapeutic Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Sarcopenia Therapeutic Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Sarcopenia Therapeutic Market Size by Type (2016-2027)
10.3 Middle East & Africa Sarcopenia Therapeutic Market Size by Application
10.3.1 Middle East & Africa Sarcopenia Therapeutic Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Sarcopenia Therapeutic Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Sarcopenia Therapeutic Market Size by Application (2016-2027)
10.4 Middle East & Africa Sarcopenia Therapeutic Market Size by Country
10.4.1 Middle East & Africa Sarcopenia Therapeutic Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Sarcopenia Therapeutic Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Details
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Sarcopenia Therapeutic Introduction
11.1.4 Abbott Laboratories Revenue in Sarcopenia Therapeutic Business (2016-2021)
11.1.5 Abbott Laboratories Recent Development
11.2 Nestlé
11.2.1 Nestlé Company Details
11.2.2 Nestlé Business Overview
11.2.3 Nestlé Sarcopenia Therapeutic Introduction
11.2.4 Nestlé Revenue in Sarcopenia Therapeutic Business (2016-2021)
11.2.5 Nestlé Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Details
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Sarcopenia Therapeutic Introduction
11.3.4 Pfizer Revenue in Sarcopenia Therapeutic Business (2016-2021)
11.3.5 Pfizer Recent Development
11.4 Amway
11.4.1 Amway Company Details
11.4.2 Amway Business Overview
11.4.3 Amway Sarcopenia Therapeutic Introduction
11.4.4 Amway Revenue in Sarcopenia Therapeutic Business (2016-2021)
11.4.5 Amway Recent Development
11.5 By-health
11.5.1 By-health Company Details
11.5.2 By-health Business Overview
11.5.3 By-health Sarcopenia Therapeutic Introduction
11.5.4 By-health Revenue in Sarcopenia Therapeutic Business (2016-2021)
11.5.5 By-health Recent Development
11.6 Usana
11.6.1 Usana Company Details
11.6.2 Usana Business Overview
11.6.3 Usana Sarcopenia Therapeutic Introduction
11.6.4 Usana Revenue in Sarcopenia Therapeutic Business (2016-2021)
11.6.5 Usana Recent Development
11.7 A&Z Pharmaceutical
11.7.1 A&Z Pharmaceutical Company Details
11.7.2 A&Z Pharmaceutical Business Overview
11.7.3 A&Z Pharmaceutical Sarcopenia Therapeutic Introduction
11.7.4 A&Z Pharmaceutical Revenue in Sarcopenia Therapeutic Business (2016-2021)
11.7.5 A&Z Pharmaceutical Recent Development
11.8 GlaxoSmithKline
11.8.1 GlaxoSmithKline Company Details
11.8.2 GlaxoSmithKline Business Overview
11.8.3 GlaxoSmithKline Sarcopenia Therapeutic Introduction
11.8.4 GlaxoSmithKline Revenue in Sarcopenia Therapeutic Business (2016-2021)
11.8.5 GlaxoSmithKline Recent Development
11.9 Bayer
11.9.1 Bayer Company Details
11.9.2 Bayer Business Overview
11.9.3 Bayer Sarcopenia Therapeutic Introduction
11.9.4 Bayer Revenue in Sarcopenia Therapeutic Business (2016-2021)
11.9.5 Bayer Recent Development
11.10 H&H
11.10.1 H&H Company Details
11.10.2 H&H Business Overview
11.10.3 H&H Sarcopenia Therapeutic Introduction
11.10.4 H&H Revenue in Sarcopenia Therapeutic Business (2016-2021)
11.10.5 H&H Recent Development
11.11 Blackmores
11.11.1 Blackmores Company Details
11.11.2 Blackmores Business Overview
11.11.3 Blackmores Sarcopenia Therapeutic Introduction
11.11.4 Blackmores Revenue in Sarcopenia Therapeutic Business (2016-2021)
11.11.5 Blackmores Recent Development
11.12 Zhendong Group
11.12.1 Zhendong Group Company Details
11.12.2 Zhendong Group Business Overview
11.12.3 Zhendong Group Sarcopenia Therapeutic Introduction
11.12.4 Zhendong Group Revenue in Sarcopenia Therapeutic Business (2016-2021)
11.12.5 Zhendong Group Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Sarcopenia Therapeutic Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Protein Supplement
Table 3. Key Players of Calcium Supplement
Table 4. Key Players of Other
Table 5. Global Sarcopenia Therapeutic Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Sarcopenia Therapeutic Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Sarcopenia Therapeutic Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Sarcopenia Therapeutic Market Share by Regions (2016-2021)
Table 9. Global Sarcopenia Therapeutic Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Sarcopenia Therapeutic Market Share by Regions (2022-2027)
Table 11. Sarcopenia Therapeutic Market Trends
Table 12. Sarcopenia Therapeutic Market Drivers
Table 13. Sarcopenia Therapeutic Market Challenges
Table 14. Sarcopenia Therapeutic Market Restraints
Table 15. Global Sarcopenia Therapeutic Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Sarcopenia Therapeutic Market Share by Players (2016-2021)
Table 17. Global Top Sarcopenia Therapeutic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Sarcopenia Therapeutic as of 2020)
Table 18. Ranking of Global Top Sarcopenia Therapeutic Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Sarcopenia Therapeutic Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Sarcopenia Therapeutic Product Solution and Service
Table 22. Date of Enter into Sarcopenia Therapeutic Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Sarcopenia Therapeutic Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Sarcopenia Therapeutic Revenue Market Share by Type (2016-2021)
Table 26. Global Sarcopenia Therapeutic Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Sarcopenia Therapeutic Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Sarcopenia Therapeutic Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Sarcopenia Therapeutic Revenue Market Share by Application (2016-2021)
Table 30. Global Sarcopenia Therapeutic Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Sarcopenia Therapeutic Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Sarcopenia Therapeutic Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Sarcopenia Therapeutic Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Sarcopenia Therapeutic Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Sarcopenia Therapeutic Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Sarcopenia Therapeutic Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Sarcopenia Therapeutic Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Sarcopenia Therapeutic Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Sarcopenia Therapeutic Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Sarcopenia Therapeutic Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Sarcopenia Therapeutic Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Sarcopenia Therapeutic Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Sarcopenia Therapeutic Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Sarcopenia Therapeutic Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Sarcopenia Therapeutic Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Sarcopenia Therapeutic Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Sarcopenia Therapeutic Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Sarcopenia Therapeutic Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Sarcopenia Therapeutic Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Sarcopenia Therapeutic Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Sarcopenia Therapeutic Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Sarcopenia Therapeutic Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Sarcopenia Therapeutic Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Sarcopenia Therapeutic Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Sarcopenia Therapeutic Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Sarcopenia Therapeutic Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Sarcopenia Therapeutic Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Sarcopenia Therapeutic Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Sarcopenia Therapeutic Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Sarcopenia Therapeutic Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Sarcopenia Therapeutic Market Size by Country (2022-2027) & (US$ Million)
Table 62. Abbott Laboratories Company Details
Table 63. Abbott Laboratories Business Overview
Table 64. Abbott Laboratories Sarcopenia Therapeutic Product
Table 65. Abbott Laboratories Revenue in Sarcopenia Therapeutic Business (2016-2021) & (US$ Million)
Table 66. Abbott Laboratories Recent Development
Table 67. Nestlé Company Details
Table 68. Nestlé Business Overview
Table 69. Nestlé Sarcopenia Therapeutic Product
Table 70. Nestlé Revenue in Sarcopenia Therapeutic Business (2016-2021) & (US$ Million)
Table 71. Nestlé Recent Development
Table 72. Pfizer Company Details
Table 73. Pfizer Business Overview
Table 74. Pfizer Sarcopenia Therapeutic Product
Table 75. Pfizer Revenue in Sarcopenia Therapeutic Business (2016-2021) & (US$ Million)
Table 76. Pfizer Recent Development
Table 77. Amway Company Details
Table 78. Amway Business Overview
Table 79. Amway Sarcopenia Therapeutic Product
Table 80. Amway Revenue in Sarcopenia Therapeutic Business (2016-2021) & (US$ Million)
Table 81. Amway Recent Development
Table 82. By-health Company Details
Table 83. By-health Business Overview
Table 84. By-health Sarcopenia Therapeutic Product
Table 85. By-health Revenue in Sarcopenia Therapeutic Business (2016-2021) & (US$ Million)
Table 86. By-health Recent Development
Table 87. Usana Company Details
Table 88. Usana Business Overview
Table 89. Usana Sarcopenia Therapeutic Product
Table 90. Usana Revenue in Sarcopenia Therapeutic Business (2016-2021) & (US$ Million)
Table 91. Usana Recent Development
Table 92. A&Z Pharmaceutical Company Details
Table 93. A&Z Pharmaceutical Business Overview
Table 94. A&Z Pharmaceutical Sarcopenia Therapeutic Product
Table 95. A&Z Pharmaceutical Revenue in Sarcopenia Therapeutic Business (2016-2021) & (US$ Million)
Table 96. A&Z Pharmaceutical Recent Development
Table 97. GlaxoSmithKline Company Details
Table 98. GlaxoSmithKline Business Overview
Table 99. GlaxoSmithKline Revenue in Sarcopenia Therapeutic Business (2016-2021) & (US$ Million)
Table 100. GlaxoSmithKline Recent Development
Table 101. Bayer Company Details
Table 102. Bayer Business Overview
Table 103. Bayer Sarcopenia Therapeutic Product
Table 104. Bayer Revenue in Sarcopenia Therapeutic Business (2016-2021) & (US$ Million)
Table 105. Bayer Recent Development
Table 106. H&H Company Details
Table 107. H&H Business Overview
Table 108. H&H Sarcopenia Therapeutic Product
Table 109. H&H Revenue in Sarcopenia Therapeutic Business (2016-2021) & (US$ Million)
Table 110. H&H Recent Development
Table 111. Blackmores Company Details
Table 112. Blackmores Business Overview
Table 113. Blackmores Sarcopenia Therapeutic Product
Table 114. Blackmores Revenue in Sarcopenia Therapeutic Business (2016-2021) & (US$ Million)
Table 115. Blackmores Recent Development
Table 116. Zhendong Group Company Details
Table 117. Zhendong Group Business Overview
Table 118. Zhendong Group Sarcopenia Therapeutic Product
Table 119. Zhendong Group Revenue in Sarcopenia Therapeutic Business (2016-2021) & (US$ Million)
Table 120. Zhendong Group Recent Development
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Sarcopenia Therapeutic Market Share by Type: 2020 VS 2027
Figure 2. Protein Supplement Features
Figure 3. Calcium Supplement Features
Figure 4. Other Features
Figure 5. Global Sarcopenia Therapeutic Market Share by Application: 2020 VS 2027
Figure 6. Online Pharmacies Case Studies
Figure 7. Retail Pharmacies Case Studies
Figure 8. Sarcopenia Therapeutic Report Years Considered
Figure 9. Global Sarcopenia Therapeutic Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Sarcopenia Therapeutic Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Sarcopenia Therapeutic Market Share by Regions: 2020 VS 2027
Figure 12. Global Sarcopenia Therapeutic Market Share by Regions (2022-2027)
Figure 13. Global Sarcopenia Therapeutic Market Share by Players in 2020
Figure 14. Global Top Sarcopenia Therapeutic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Sarcopenia Therapeutic as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Sarcopenia Therapeutic Revenue in 2020
Figure 16. Global Sarcopenia Therapeutic Revenue Market Share by Type (2016-2021)
Figure 17. Global Sarcopenia Therapeutic Revenue Market Share by Type (2022-2027)
Figure 18. North America Sarcopenia Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Sarcopenia Therapeutic Market Share by Type (2016-2027)
Figure 20. North America Sarcopenia Therapeutic Market Share by Application (2016-2027)
Figure 21. North America Sarcopenia Therapeutic Market Share by Country (2016-2027)
Figure 22. United States Sarcopenia Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Sarcopenia Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Sarcopenia Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Sarcopenia Therapeutic Market Share by Type (2016-2027)
Figure 26. Europe Sarcopenia Therapeutic Market Share by Application (2016-2027)
Figure 27. Europe Sarcopenia Therapeutic Market Share by Country (2016-2027)
Figure 28. Germany Sarcopenia Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Sarcopenia Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Sarcopenia Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Sarcopenia Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Sarcopenia Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Sarcopenia Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Sarcopenia Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Sarcopenia Therapeutic Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Sarcopenia Therapeutic Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Sarcopenia Therapeutic Market Share by Region (2016-2027)
Figure 38. China Sarcopenia Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Sarcopenia Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Sarcopenia Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Sarcopenia Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Sarcopenia Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Sarcopenia Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Sarcopenia Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Sarcopenia Therapeutic Market Share by Type (2016-2027)
Figure 46. Latin America Sarcopenia Therapeutic Market Share by Application (2016-2027)
Figure 47. Latin America Sarcopenia Therapeutic Market Share by Country (2016-2027)
Figure 48. Mexico Sarcopenia Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Sarcopenia Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Sarcopenia Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Sarcopenia Therapeutic Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Sarcopenia Therapeutic Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Sarcopenia Therapeutic Market Share by Country (2016-2027)
Figure 54. Turkey Sarcopenia Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Sarcopenia Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Sarcopenia Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Abbott Laboratories Revenue Growth Rate in Sarcopenia Therapeutic Business (2016-2021)
Figure 58. Nestlé Revenue Growth Rate in Sarcopenia Therapeutic Business (2016-2021)
Figure 59. Pfizer Revenue Growth Rate in Sarcopenia Therapeutic Business (2016-2021)
Figure 60. Amway Revenue Growth Rate in Sarcopenia Therapeutic Business (2016-2021)
Figure 61. By-health Revenue Growth Rate in Sarcopenia Therapeutic Business (2016-2021)
Figure 62. Usana Revenue Growth Rate in Sarcopenia Therapeutic Business (2016-2021)
Figure 63. A&Z Pharmaceutical Revenue Growth Rate in Sarcopenia Therapeutic Business (2016-2021)
Figure 64. GlaxoSmithKline Revenue Growth Rate in Sarcopenia Therapeutic Business (2016-2021)
Figure 65. Bayer Revenue Growth Rate in Sarcopenia Therapeutic Business (2016-2021)
Figure 66. H&H Revenue Growth Rate in Sarcopenia Therapeutic Business (2016-2021)
Figure 67. Blackmores Revenue Growth Rate in Sarcopenia Therapeutic Business (2016-2021)
Figure 68. Zhendong Group Revenue Growth Rate in Sarcopenia Therapeutic Business (2016-2021)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
世界のサルコペニア治療サプリメント市場規模・現状・予測（2021年-2027年） There is no approved treatment option available for sarcopenia treatment but nutrition and dietary supplements have a key role in sarcopenia treatment.Major Sarcopenia treatment supplement comprises of protein, amino acids, creatine, omega 3 acid, vitamin D and B12, calcium carbonate. Nutrition prev…- 世界の外分泌膵機能不全治療市場規模・現状・予測（2021年-2027年） Exocrine pancreatic insufficiency refers to a medical condition which is characterized by the deficiency of the exocrine pancreatic enzymes. Market Analysis and Insights: Global Exocrine Pancreatic Insufficiency Therapeutic Market The global Exocrine Pancreatic Insufficiency Therapeutic market size …
- 世界のB型肝炎用治療薬市場規模・現状・予測（2021年-2027年） Treatment for chronic hepatitis B may include: Antiviral medications. Several antiviral medications — including entecavir (Baraclude), tenofovir (Viread), lamivudine (Epivir), adefovir (Hepsera) and telbivudine (Tyzeka) — can help fight the virus and slow its ability to damage your liver. Market Ana…
- 世界のアフェレシス療法市場規模・現状・予測（2021年-2027年） Therapeutic apheresis is a procedure of the removal of a blood component from a patient using the apheresis technology. Therapeutic apheresis is used for the purpose of removing defective cells. Therapeutic apheresis is also used for the treatment of conditions in which a component or a pathogenic s…
- 世界のマゴットセラピー市場規模・現状・予測（2021年-2027年） Maggot therapy is a type of biotherapy involving the introduction of live, disinfected maggots (fly larvae) into the non-healing skin and soft tissue wound(s) of a human or animal for the purpose of cleaning out the necrotic (dead) tissue within a wound (debridement) and disinfection. North America …